Employing recombinant viruses expressing LMP1 and LMP2A for the infection of transgenic LMP1/CD30 mice will enable the examination of the additional impact of crucial EBV proteins on the development of these lymphomas. This evidence concerns the gene PDLIM7 and lymphoma.